Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CN Stock MarketDetailed Quotes
Chengdu Kanghong Pharmaceutical Group (002773)
- 33.18
- -0.33-0.98%
Trading Jan 16 11:12 CST
30.57BMarket Cap24.45P/E (TTM)
33.92High33.14Low41.23KlotVolume33.61Open33.51Prev Close137.99MTurnover0.60%Turnover Ratio25.66P/E (Static)921.32MShares47.3752wk High3.34P/B22.79BFloat Cap18.2552wk Low36.86Limit Up686.83MShs Float52.11Historical High30.16Limit Down2.33%Range %6.12Historical Low0.60Dividend TTM33.47Avg Price24.54KlotAsk1.81%Div Yield TTM100Lot Size14.66KlotBid
Chengdu Kanghong Pharmaceutical Group (002773) Balance Sheet
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 15.13%3.83B | 11.14%3.33B | 10.39%3.44B | 21.00%5.69B | 31.59%3.33B | 0.61%3B | 45.62%3.11B | 31.15%4.7B | 60.99%2.53B | 72.81%2.98B |
| Transactional financial assets | 15.54%2.57B | 25.71%2.67B | 35.33%2.64B | ---- | 12.69%2.22B | 98.69%2.12B | 15.67%1.95B | ---- | 22.21%1.97B | -14.54%1.07B |
| Notes receivable and accounts receivable | -4.41%166.93M | -6.90%202.38M | 16.39%198.06M | 10.88%177.85M | -6.23%174.62M | 17.26%217.37M | -24.34%170.17M | -0.17%160.41M | -10.44%186.22M | -23.19%185.37M |
| -Notes receivable | -65.13%185.56K | ---- | --600K | --371.11K | -80.45%532.08K | ---- | ---- | ---- | -87.03%2.72M | -88.03%3.02M |
| -Accounts receivable | -4.22%166.74M | -6.90%202.38M | 16.03%197.46M | 10.64%177.48M | -5.13%174.09M | 19.20%217.37M | -22.40%170.17M | 7.21%160.41M | -1.85%183.5M | -15.63%182.36M |
| Other receivables (including interest and dividends) | -45.69%8.98M | -45.39%6.65M | -36.79%11.75M | -46.34%3.78M | 61.52%16.53M | 71.96%12.18M | -1.40%18.59M | -35.87%7.05M | -43.78%10.23M | -27.72%7.09M |
| -Other receivable | ---- | -45.39%6.65M | ---- | ---- | ---- | 71.96%12.18M | ---- | -35.87%7.05M | ---- | -27.72%7.09M |
| Advance payment | 1.89%42.38M | 21.13%30.93M | 68.57%31.49M | 9.29%11.46M | 28.17%41.59M | -6.77%25.53M | -45.20%18.68M | -56.37%10.48M | -15.68%32.45M | -10.36%27.39M |
| Inventories | -4.49%386.24M | -10.51%373.45M | -9.27%364.32M | -4.15%386.86M | 7.25%404.42M | 14.00%417.32M | 17.16%401.55M | 21.95%403.61M | 22.05%377.07M | 24.75%366.07M |
| Other current assets | 21.42%25.56M | -10.79%20.29M | -31.40%16.06M | -11.68%19.36M | 32.17%21.05M | -4.37%22.75M | 15.71%23.41M | 28.24%21.92M | 26.56%15.93M | -5.72%23.79M |
| Total current assets | 13.22%7.02B | 14.06%6.63B | 17.59%6.7B | 18.53%6.29B | 21.19%6.2B | 24.84%5.81B | 27.57%5.7B | 25.45%5.31B | 35.86%5.12B | 30.33%4.66B |
| Non Current assets | ||||||||||
| Long-term equity investment | -3.65%15.97M | -2.76%16.21M | -2.49%16.31M | -2.00%16.44M | -0.92%16.58M | -0.55%16.67M | -0.87%16.72M | -1.22%16.78M | -3.33%16.73M | -4.17%16.76M |
| Fixed assets | ---- | -5.27%2.15B | ---- | ---- | ---- | 1.56%2.27B | ---- | 8.44%2.24B | ---- | 79.87%2.23B |
| Fixed assets liquidation | ---- | --17.19K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Constru in process | ---- | 66.18%126.26M | ---- | ---- | ---- | -67.03%75.98M | ---- | -65.00%166.54M | ---- | -78.38%230.48M |
| Productive biological assets | -31.09%3.74M | -31.45%4.04M | 7.00%4.36M | 2.14%4.65M | 11.80%5.43M | 5.34%5.89M | -50.61%4.07M | -47.13%4.55M | -39.42%4.86M | -33.73%5.59M |
| Intangible assets | 23.68%363.12M | 23.63%372.51M | -9.67%279.27M | -9.44%286.89M | -8.42%293.6M | -6.57%301.32M | -4.02%309.15M | -4.33%316.8M | -3.00%320.61M | -3.42%322.53M |
| Development expenditure | -66.50%35.58M | -70.72%27.66M | 30.70%122.22M | 26.77%116.81M | 28.29%106.21M | 26.82%94.48M | 39.89%93.52M | 48.67%92.14M | 92.97%82.79M | 160.68%74.5M |
| Long deferred expense | -64.57%1.7M | -11.99%5.16M | -10.20%5.55M | -10.57%6.43M | -24.60%4.81M | -20.48%5.87M | -20.22%6.18M | -15.25%7.19M | -26.96%6.38M | -24.62%7.38M |
| Deferred tax assets | -43.83%136.31M | -35.32%175.88M | -30.88%215.83M | -27.54%259.46M | -37.16%242.66M | -36.83%271.94M | -33.07%312.28M | -26.37%358.08M | -21.61%386.19M | -15.53%430.48M |
| Usufruct assets | -33.08%3.97M | -20.36%4.43M | 143.85%4.85M | 149.12%5.29M | 75.96%5.94M | 44.30%5.57M | -52.34%1.99M | -54.94%2.12M | -35.87%3.38M | -32.56%3.86M |
| Other non current assets | 51.20%33.48M | 26.38%21.19M | -35.16%15.4M | -34.73%14.37M | -19.69%22.14M | -53.55%16.77M | -28.90%23.75M | -35.11%22.01M | -95.45%27.57M | -93.03%36.09M |
| Total non current assets | -5.41%2.85B | -5.25%2.9B | -5.18%2.97B | -5.30%3.05B | -8.07%3.01B | -8.88%3.06B | -8.60%3.14B | -7.66%3.22B | -14.84%3.27B | -10.13%3.36B |
| Total assets | 7.13%9.87B | 7.40%9.53B | 9.50%9.67B | 9.52%9.34B | 9.78%9.21B | 10.71%8.88B | 11.85%8.83B | 10.48%8.53B | 10.25%8.39B | 9.64%8.02B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | -14.43%208.57M | -0.47%265.26M | -4.71%243.92M | -13.62%297.16M | -19.15%243.74M | -21.68%266.52M | -24.23%255.97M | -16.00%344.03M | -0.54%301.45M | 20.38%340.28M |
| -Accounts payable | -14.43%208.57M | -0.47%265.26M | -4.71%243.92M | -13.62%297.16M | -19.15%243.74M | -21.68%266.52M | -24.23%255.97M | -16.00%344.03M | -0.54%301.45M | 20.38%340.28M |
| Contract liabilities | 40.54%5.36M | 163.37%17.19M | 46.44%9.76M | 74.95%8.92M | -44.18%3.82M | 4.68%6.53M | 79.56%6.67M | -44.21%5.1M | 37.21%6.84M | -3.03%6.23M |
| Advance receipts | -6.85%4.52M | -62.23%1.64M | -50.95%7.98M | 17.78%4.57M | 21.23%4.85M | 63.89%4.35M | 161.18%16.27M | 92.91%3.88M | 25.16%4M | -65.38%2.65M |
| Salaries payable | 10.88%27.11M | 8.76%45.46M | 11.29%43.05M | 9.92%147.28M | 6.65%24.45M | 4.17%41.8M | -1.13%38.68M | 30.73%133.98M | 5.23%22.93M | 80.73%40.13M |
| Taxs payable | 27.72%65.39M | -1.70%49.21M | 9.34%60.38M | 43.20%51.49M | -7.71%51.2M | 6.44%50.06M | -29.47%55.22M | -12.45%35.95M | 2.33%55.47M | -26.46%47.03M |
| Other payable (including interest and dividends) | -9.84%303.51M | -5.85%226.67M | 9.06%197.88M | -2.35%62.84M | 25.45%336.64M | 63.28%240.75M | 65.48%181.44M | -2.24%64.36M | 16.82%268.34M | 1.52%147.44M |
| -Other payable | ---- | -5.85%226.67M | ---- | ---- | ---- | 63.28%240.75M | ---- | -2.24%64.36M | ---- | 1.52%147.44M |
| Non current liabilities due within one year | -38.75%1.47M | -30.43%1.66M | 250.00%1.43M | 226.04%1.73M | 84.31%2.41M | 41.27%2.38M | -11.33%407.56K | -66.72%531.82K | -26.42%1.31M | -12.28%1.68M |
| Other current liabilities | -8.98%62.26M | -31.92%39.33M | -46.06%21.49M | 21.62%80.99M | 20.79%68.4M | 17.25%57.76M | 26.89%39.83M | 7.44%66.59M | -22.01%56.63M | -23.38%49.26M |
| Total current liabilities | -7.79%678.19M | -3.54%646.42M | -1.45%585.89M | 0.09%654.99M | 2.58%735.49M | 5.58%670.14M | -2.01%594.5M | -5.66%654.43M | 3.71%716.96M | 6.78%634.71M |
| Current liabilities | ||||||||||
| Long term account payable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| Specific account payable | ---- | -63.90%6.38M | ---- | ---- | ---- | -71.22%17.66M | ---- | -58.65%36.6M | ---- | -48.23%61.37M |
| Deferred tax liabilities | -5.28%10.47M | -2.68%10.16M | 55.41%13.33M | 64.05%13.03M | 60.67%11.05M | 66.21%10.44M | 51.62%8.58M | 54.56%7.94M | 276.06%6.88M | 229.59%6.28M |
| Long term deferred income | 18.15%20.92M | 2.85%18.64M | 2.52%19M | -4.74%16.49M | -19.62%17.7M | -19.25%18.12M | -18.90%18.54M | -25.63%17.31M | 3.94%22.02M | -0.46%22.44M |
| Lease liabilities | -43.16%2.2M | -36.00%2.07M | 52.37%2.31M | 134.37%3.47M | 134.39%3.88M | 79.55%3.24M | -63.40%1.52M | -54.73%1.48M | -49.08%1.65M | -43.10%1.8M |
| Other non current liabilities | ---- | ---- | --240.51K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | -2.26%41.79M | -24.70%37.25M | -24.95%41.64M | -36.72%40.08M | -46.41%42.76M | -46.17%49.46M | -47.97%55.48M | -47.31%63.33M | -38.90%79.79M | -37.12%91.9M |
| Total liabilities | -7.49%719.98M | -4.99%683.67M | -3.45%627.52M | -3.16%695.07M | -2.32%778.25M | -0.96%719.61M | -8.88%649.98M | -11.81%717.76M | -3.06%796.75M | -1.88%726.61M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.17%921.32M | 0.17%921.3M | 0.04%919.87M | 0.03%919.78M | 0.03%919.78M | 0.03%919.76M | 0.00%919.46M | 0.00%919.46M | 0.00%919.46M | 0.00%919.46M |
| Capital reserve funds | 1.59%2.03B | 1.56%2.03B | 0.42%2B | 0.35%2B | 0.43%2B | 0.04%2B | -0.22%1.99B | -0.22%1.99B | -0.23%1.99B | 0.26%2B |
| Surplus reserve funds | 0.00%515.32M | 0.00%515.32M | 0.00%515.32M | 0.00%515.32M | 5.24%515.32M | 5.78%515.32M | 5.95%515.32M | 7.16%515.32M | 3.13%489.68M | 3.15%487.16M |
| Retained profit | 13.94%5.7B | 14.31%5.4B | 18.26%5.62B | 19.22%5.22B | 19.54%5.01B | 21.44%4.72B | 25.70%4.75B | 24.86%4.38B | 24.15%4.19B | 23.19%3.89B |
| Other composite income | -10.78%-1.65M | 23.14%-1.39M | 4.24%-1.85M | 1.02%-1.33M | -18.66%-1.49M | -65.08%-1.81M | -41.95%-1.93M | -27.74%-1.34M | -96.30%-1.26M | 6.54%-1.1M |
| Shareholders equity without minority interests | 8.66%9.17B | 8.70%8.86B | 10.73%9.05B | 10.88%8.65B | 11.24%8.44B | 11.83%8.15B | 13.87%8.18B | 13.07%7.8B | 12.20%7.58B | 11.50%7.29B |
| Minority interests | -1,645.76%-16.31M | -730.77%-13.9M | -261.92%-9.46M | -180.32%-6.34M | -107.54%-934.11K | 493.27%2.2M | 98.93%5.84M | 55.52%7.89M | -60.15%12.39M | -101.72%-560.35K |
| Total shareholder equity | 8.48%9.15B | 8.50%8.85B | 10.53%9.05B | 10.69%8.65B | 11.05%8.43B | 11.87%8.16B | 13.91%8.18B | 13.10%7.81B | 11.86%7.6B | 10.94%7.29B |
| Total liabilityies and equity | 7.13%9.87B | 7.40%9.53B | 9.50%9.67B | 9.52%9.34B | 9.78%9.21B | 10.71%8.88B | 11.85%8.83B | 10.48%8.53B | 10.25%8.39B | 9.64%8.02B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | -- | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"